U.S. Market Growth for Iron Deficiency Anemia Therapy:

In the United States, the iron deficiency anemia therapy market is experiencing steady expansion, driven by increasing awareness, advanced healthcare infrastructure, and rising prevalence among specific groups such as women, the elderly, and patients with chronic diseases. The market is supported by strong screening programs and the availability of innovative treatment options, including newer oral and intravenous iron formulations that reduce side effects and improve patient compliance. The growing adoption of parenteral iron therapies and ongoing clinical research into improved iron delivery systems are also contributing to sustained market growth. Overall, the U.S. market remains mature but continues to offer significant opportunities as technological advancements and patient-focused treatments gain traction.

Asia Pacific Iron Deficiency Anemia Therapy Market Analysis:

In the future, the Asia Pacific is anticipated to expand rapidly in the iron deficiency anemia therapy market. A rise in IDA incidences is mainly driven by poor dietary intake, genetic factors, and chronic conditions among the ASAP population. For this, various countries' governments are promoting different government campaigns and public health initiatives to raise awareness about these concerns.

For instance,

• In September 2025, India implemented the Anemia Mukt Bharat strategy for the reduction of anaemia among six beneficiary age groups: children (6-59 months), children (5-9 years), adolescents (10-19 years), pregnant and lactating women and women of reproductive age group (15-49 years) in the life cycle.
  

India Market Growth for Iron Deficiency Anemia Therapy

In India, the iron deficiency anemia therapy market is growing rapidly due to a combination of public health initiatives, rising healthcare access, and increasing awareness about the importance of early diagnosis and treatment. Government-led programs targeting women and children have significantly boosted demand for iron and folic acid supplementation, while hospitals and clinics are expanding the use of intravenous iron formulations to treat moderate to severe cases. The country's large population base, coupled with ongoing improvements in healthcare infrastructure, is fueling strong market expansion. However, challenges such as affordability, limited access in rural regions, and low adherence to long-term therapy still constrain optimal growth. Despite these hurdles, India remains one of the most promising markets for iron deficiency anemia therapies in the coming years.

Segmental Insights

By Therapy Type Analysis:

Which Therapy Type Led the Iron Deficiency Anemia Therapy Market in 2024?

The parenteral iron therapy segment captured a dominant share of the market in 2024. This is the most efficacious and rapid therapy used in numerous chronic diseases, as well as ongoing breakthroughs in IV formulations are enhancing safety and lowering side effects. Alongside, they possess wider beneficial effects in heart failure, certain bariatric surgery patients, and those with RLS. Recently, the US FDA approved a generic version of iron sucrose injection, USP, for the treatment of IDA in adults and pediatric patients (2 years and older) with CKD.

Whereas the oral iron therapy segment is predicted to grow at a rapid CAGR. Its affordability and ease of administration are making it the patient's preference. Many pharmaceutical companies

By Age Group Analysis:

Why did the Adults Segment Dominate the Market in 2024?

In 2024, the adults segment held the biggest share of the iron deficiency anemia therapy market. This mainly consists of women of childbearing age, pregnant women, and those with chronic diseases, including chronic kidney disease or cancer. In the growing heart failure cases, IV iron is recommended for iron-deficient patients with HF (NYHA class II or III) with its improved quality of life, functional capacity, and lowered rehospitalizations.

On the other hand, the pediatric segment is anticipated to witness the fastest growth. Because of poor dietary intake, infants and toddlers (under 5) and adolescents are facing IDA. Nowadays, different regions are bolstering iron supplementation and nutrition programs. Expanded dietary consultations suggest enriching the empty stomach with vitamin C-rich foods and reducing excessive cow's milk consumption.

Get the latest insights on life science industry segmentation with our Annual Membership:

By End-user Analysis:

What Made the Hospitals Segment Dominant in the Market in 2024?

The hospitals segment registered dominance with a major revenue share of the iron deficiency anemia therapy market in 2024. They possess well-equipped management solutions for anemia associated with chronic conditions. Also, they offer a setting for complex cases that need a team of specialists, advanced diagnostics, and comprehensive treatment plans. The emergence of hospital-based therapies gives better reimbursement and insurance coverage, which is also impacting the segmental growth.

Moreover, the home healthcare segment is predicted to grow at a rapid CAGR. The globe is shifting towards convenient approaches, with affordability and reduced hospital visits boosting the adoption of home healthcare

What are the Key Developments in the Iron Deficiency Anemia Therapy Market?

• In June 2025, Wanbury Limited launched 'Wanbury Cred', a novel iron supplement created to eliminate iron deficiency and anaemia.
• In July 2025, One A Day®, the multivitamin and supplement brand, launched first of its first-of-its-kind One A Day® Kids Multi with Iron to support filling nutrient gaps in kids.

Browse More Insights of Towards Healthcare:

The global cell and gene therapy manufacturing quality control (QC) market

The global cell and gene therapy (CGT) pharmaceuticals market

The global cell and gene therapy cold chain logistics market

The global cell and gene therapy drug delivery devices market

The global cell and gene therapy contract research organization (CRO) market

The global cell and gene therapy (CGT) biomanufacturing market

The global gene therapy cell culture media market

The global gene therapy for sickle cell disease market

The global cell and gene therapy isolator market

Meanwhile, the global proton therapy systems market

Iron Deficiency Anemia Therapy Market Key Players List

• AbbVie, Inc.
• Akebia Therapeutics
• AMAG Pharmaceuticals
• CSL Vifor
• Daiichi Sankyo Company
• Emcure Pharmaceuticals
• Ironic Biotech
• Johnson & Johnson
• Kye Pharmaceuticals
• Pharmacosmos Therapeutics
• Shield Therapeutics
• Teva Pharmaceuticals

Segments Covered in the Report

By Therapy Type

• Parenteral Iron Therapy
• Oral Iron Therapy
• Red Blood Cell Transfusion
• Others

By Age Group

• Adults
• Pediatric
• Geriatric
  

By End-User

• Hospitals
• Home Healthcare
• Clinics
  

By Region

• North America
  • US
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Thailand
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Sweden
  • Denmark
  • Norway
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • UAE
  • Saudi Arabia
  • Kuwait
    

Immediate Delivery Available | Buy This Premium Research @

Access our exclusive, data-rich dashboard dedicated to the healthcare market - built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.

Access the Dashboard:

About Us

Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research

You can place an order or ask any questions, please feel free to contact us at ...

Europe Region: +44 778 256 0738

North America Region: +1 8044 4193 44

APAC Region: +91 9356 9282 04

Web:

Our Trusted Data Partners

Precedence Research | Statifacts | Towards Packaging | Towards Automotive | Towards Food and Beverages | Towards Chemical and Materials | Towards Consumer Goods | Towards Dental | Towards EV Solutions | Nova One Advisor | Healthcare Webwire | Packaging Webwire | Automotive Webwire | Nutraceuticals Func Foods | Onco Quant | Sustainability Quant | Specialty Chemicals Analytics

Find us on social platforms: LinkedIn | Twitter | Instagram | Medium | Pinterest